192 related articles for article (PubMed ID: 19845822)
1. Treatment of scalp psoriasis with clobetasol-17 propionate 0.05% shampoo: a study on daily clinical practice.
Bovenschen HJ; Van de Kerkhof PC
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):439-44. PubMed ID: 19845822
[TBL] [Abstract][Full Text] [Related]
2. Clobetasol propionate shampoo 0.05%: a new option to treat patients with moderate to severe scalp psoriasis.
Jarratt M; Breneman D; Gottlieb AB; Poulin Y; Liu Y; Foley V
J Drugs Dermatol; 2004; 3(4):367-73. PubMed ID: 15303780
[TBL] [Abstract][Full Text] [Related]
3. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis.
Poulin Y; Papp K; Bissonnette R; Barber K; Kerrouche N; Villemagne H;
J Dermatolog Treat; 2010 May; 21(3):185-92. PubMed ID: 20131980
[TBL] [Abstract][Full Text] [Related]
4. Clobetasol propionate shampoo 0.05% and calcipotriol solution 0.005%: a randomized comparison of efficacy and safety in subjects with scalp psoriasis.
Reygagne P; Mrowietz U; Decroix J; de Waard-van der Spek FB; Acebes LO; Figueiredo A; Caputo R; Poncet M; Arsonnaud S
J Dermatolog Treat; 2005 Feb; 16(1):31-6. PubMed ID: 15897165
[TBL] [Abstract][Full Text] [Related]
5. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
Andres P; Poncet M; Farzaneh S; Soto P
J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
[TBL] [Abstract][Full Text] [Related]
6. A randomized, investigator-masked clinical evaluation of the efficacy and safety of clobetasol propionate 0.05% shampoo and tar blend 1% shampoo in the treatment of moderate to severe scalp psoriasis.
Griffiths CE; Finlay AY; Fleming CJ; Barker JN; Mizzi F; Arsonnaud S
J Dermatolog Treat; 2006; 17(2):90-5. PubMed ID: 16766333
[TBL] [Abstract][Full Text] [Related]
7. Short-contact clobetasol propionate shampoo 0.05% improves quality of life in patients with scalp psoriasis.
Tan J; Thomas R; Wang B; Gratton D; Vender R; Kerrouche N; Villemagne H;
Cutis; 2009 Mar; 83(3):157-64. PubMed ID: 19363909
[TBL] [Abstract][Full Text] [Related]
8. Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of scalp psoriasis.
Poulin Y; Papp K; Bissonnette R; Guenther L; Tan J; Lynde C; Kerrouche N; Villemagne H;
Cutis; 2010 Jan; 85(1):43-50. PubMed ID: 20184211
[TBL] [Abstract][Full Text] [Related]
9. Clobetasol propionate 0.05% spray for the management of moderate-to-severe plaque psoriasis of the scalp: results from a randomized controlled trial.
Sofen H; Hudson CP; Cook-Bolden FE; Preston N; Colón LE; Colón LE; Caveney SW; Gottschalk RW
J Drugs Dermatol; 2011 Aug; 10(8):885-92. PubMed ID: 21818510
[TBL] [Abstract][Full Text] [Related]
10. Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.
Austad J; Bjerke JR; Gjertsen BT; Helland S; Livden JK; Morken T; Mørk NJ
J Eur Acad Dermatol Venereol; 1998 Jul; 11(1):19-24. PubMed ID: 9731961
[TBL] [Abstract][Full Text] [Related]
11. Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study.
Ortonne JP; Nikkels AF; Reich K; Ponce Olivera RM; Lee JH; Kerrouche N; Sidou F; Faergemann J
Br J Dermatol; 2011 Jul; 165(1):171-6. PubMed ID: 21707573
[TBL] [Abstract][Full Text] [Related]
12. Clobetasol propionate shampoo 0.05% in the treatment of seborrheic dermatitis of the scalp: results of a pilot study.
Reygagne P; Poncet M; Sidou F; Soto P
Cutis; 2007 May; 79(5):397-403. PubMed ID: 17569404
[TBL] [Abstract][Full Text] [Related]
13. Clobetasol propionate for psoriasis: are ointments really more potent?
Warino L; Balkrishnan R; Feldman SR
J Drugs Dermatol; 2006 Jun; 5(6):527-32. PubMed ID: 16774104
[TBL] [Abstract][Full Text] [Related]
14. Clobetasol propionate spray 0.05% for the treatment of moderate to severe plaque psoriasis.
Menter A
Cutis; 2012 Feb; 89(2):89-94. PubMed ID: 22474733
[TBL] [Abstract][Full Text] [Related]
15. An intra-individual randomized safety and efficacy comparison of clobetasol propionate 0.05% spray and its vehicle in the treatment of plaque psoriasis.
Beutner K; Chakrabarty A; Lemke S; Yu K
J Drugs Dermatol; 2006 Apr; 5(4):357-60. PubMed ID: 16673804
[TBL] [Abstract][Full Text] [Related]
16. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
17. The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis.
Housman TS; Keil KA; Mellen BG; McCarty MA; Fleischer AB; Feldman SR
J Am Acad Dermatol; 2003 Jul; 49(1):79-82. PubMed ID: 12833013
[TBL] [Abstract][Full Text] [Related]
18. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis.
Lebwohl M; Colón LE
Cutis; 2007 Nov; 80(5 Suppl):29-40. PubMed ID: 18154221
[TBL] [Abstract][Full Text] [Related]
19. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
20. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
Brodell RT; Bruce S; Hudson CP; Weiss JS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
